# Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock

Study · id `cardio:ct-nct04184635` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04184635](<https://clinicaltrials.gov/study/NCT04184635>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04184635

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.

## Technical summary

Registry record NCT04184635. Randomized; no masking; primary purpose treatment. Start 2021-10-14 (actual); primary completion 2026-10-14 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT04184635, source copy `cardio:ctgov-nct04184635-2025-01-14`, retrieved 2026-10-31)
- Started: 2021-10-14 (actual) (ClinicalTrials.gov record NCT04184635, source copy `cardio:ctgov-nct04184635-2025-01-14`, retrieved 2026-10-31)
- Primary completion: 2026-10-14 (anticipated) (ClinicalTrials.gov record NCT04184635, source copy `cardio:ctgov-nct04184635-2025-01-14`, retrieved 2026-10-31)
- Completion: 2027-10-14 (anticipated) (ClinicalTrials.gov record NCT04184635, source copy `cardio:ctgov-nct04184635-2025-01-14`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT04184635, source copy `cardio:ctgov-nct04184635-2025-01-14`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04184635-2025-01-14`, retrieved 2026-10-31)

## The registry's words

- Brief title: Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock
- Acronym: ANCHOR
- Condition: Acute Myocardial Infarction
- Condition: Cardiogenic Shock
- Intervention (Device): VA-ECMO
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: 6fa0d040bfb978876f7bcbb74787f6a0e273247f04e40b55864309bd058c60f9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
